Ayurvedic treatment for Tamaka Swasa in children

Effectiveness of Parnayavani Arka nebulization and oral administration on acute episodes of Tamaka Shwasa (Bronchial Asthma) in children (6-12 years) - AY-TS

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/07/034696

Enrollment

Registered

2021-07-08

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J452- Mild intermittent asthma

Interventions

Intervention1: Parnayavani Arka: 3ml of the Arka for nebulization every 4th hourly and 3ml of Arka is administered orally every 4th hourly for 3 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children aged 6-12 years irrespective of gender, religion, and socio-economic status. 2. Children with mild to moderate exacerbation of asthma as per GINA. 3. Those parents who are willing to participate their child in the study and ready to sign the consent form.

Exclusion criteria

Exclusion criteria: 1. Children with life threatening asthma detected by presence of any of the following: o cyanosis o High grade fever 2. Children with known case other chronic respiratory conditions like tuberculosis, cystic fibrosis or other acute illness that would complicate current treatment and response for asthma

Design outcomes

Primary

Measure	Time frame
Subjective and objective parameters of Tamaka Shwasa - Beckers Asthma Score and Peak Expiratory Flow RateTimepoint: 3 days	—

Secondary

Measure	Time frame
Patient well beingTimepoint: 3 days	—

Countries

India

Contacts

Public ContactDr Abby Chacko

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital

abtittu@gmail.com9480624829

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026